Breast Cancer Hormone Receptor-positive
📧 Sign up to get email alerts when something new happens for Breast Cancer Hormone Receptor-positive.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for ORION-1 studying AVZO-023 as a single agent and in combination with AVZO-021 and/or endocrine therapy in advanced …
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: ETHAN - ET for Male BC [Phase 2]
A Phase 2 trial named ETHAN is evaluating an ET-based therapy for male breast cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Exploration of Dalpiciclib Plus HDACi in HR+/HER2- Advanced Breast Cancer After Failure of CDK4/6 Inhibitor [Phase 2]
A Phase 2 trial is exploring the combination of dalpiciclib with a histone deacetylase inhibitor for HR+/HER2- advanced breast cancer after …
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Study of XL102 as Single-Agent and Combination Therapy in Subjects With Solid Tumors (QUARTZ-101) [Phase 1]
Exelixis reports that the QUARTZ-101 Phase 1 trial of XL102 as a single agent and in combination therapy for solid tumors has been terminate…
-
FDA approval · 2018-04-12FDA Approved: EVEROLIMUS — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s Original Application for Everolimus, establishing a generic version of the branded drug. The a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.